Mehtap AKBALIK KARA, Beltinge DEMİRCİOĞLU KILIÇ, Aslı TÜRKUT YILMAZ, Mithat BÜYÜKÇELİK, Ayşe BALAT

Evaluation of disease outcome with demographic,clinical and laboratory features of childhood-onset systemic lupus erythematosus: Single center experience

Aim: To report demographic, clinical and laboratory findings with clinical outcome in childhood-onset systemic lupus erythematosus(cSLE)Material and Methods: Charts of all children with cSLE followed at pediatric rheumatology clinic of Gaziantep University between2000-2016 were reviewed. Demographic data, history, age at diagnosis, physical examination, laboratory investigations, diagnosticcriteria, follow-up duration and all therapeutic regimens were noted. The pediatric adaptation of the Systemic Lupus InternationalCollaborating Clinics American College of Rheumatology Damage Index (PedSDI) has been used to evaluate the disease outcome.Results: The study population was consisted of 39 patients, 31 girls and 8 boys who were under 18 years at the time of diagnosis.Female: male ratio was 4.7:1. The mean age at disease onset was 10.5±4.56 years, and the mean follow-up duration was 26.4±17.8 months. At the end of the follow-up period, fifteen patients (38.5%) had accrued damage (PedSDI≥1). We observed that renal,neuropsychiatric and musculoskeletal damage was the most frequent types of damage (38.5%). The damage score was higher inpatients having increased number of diagnostic criteria at presentation (p:0.001).Conclusion: Although our study showed less damage index than patients from other countries, it has been well known that thedamage accrual in SLE is higher in long term period, and mean follow-up period of our patients is lower than previous reports. Weconclude that damage mainly affects renal, neurophyschiatric and musculoskeletal systems, and increased number of diagnosticcriteria at presentation may cause much more damage.

PDF

___

1. Stichweh D, Arce E, Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 2004;16:577-87.
2. Tucker LB, Menon S, Schaller JG, et al. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995;34:866-72.
3. Cervera R, Khamashta MA, Font J, et al. European Working Party on Systemic Lupus Erythematosus European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308.
4. Watson L, Leone V, Pilkington C, et al. UK JuvenileOnset Systemic Lupus Erythematosus Study Group. Disease activity,severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum 2012;64:2356-65.
5. Gutiérrez-Suárez R, Ruperto N, Gastaldi R, et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2006;54:2989-96.
6. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
7. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64:2677-86.
8. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
9. Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15: 241-50.
10. Gladman DD, Ibanez D, Urowitz MB, et al. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288-91.
11. Fessel WJ. Epidemiology of systemic lupus erythematosus. Rheum Dis Clin North Am 1998;14: 15-23.
12. Garcia MA, Marcos JC, Marcos AI, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus 2005;14:938-46.
13. Swaak AJ, van den Brink HG, Smeen RJ, et al. Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology 1999;38:953-8.
14. Sahin S, Adrovic A, Barut K, et al. Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome. Lupus. 2018 Mar;27:514-519.
15. Balci S, Ekinci RMK, Bayazit AK, et al. Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey. Clin Rheumatol. 2019;38:1459-68.
16. Hiraki LT, Benseler SM, Tyrrell PN, et al. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J.Pediatr 2008;152:550-6.
17. Koutsonikoli A, Trachana M, Heidich AB,et al. Dissecting the damage in Northern Greek patients with childhood-onset systemic lupus erythematosus: a retrospective cohort study. Rheumatol Int J 2015;35:1225-32.
18. Salah S, Lotfy HM, Mokbel AN, et al. Damage index in childhood-onset systemic lupus erythematosus in Egypt. Pediatr Rheumatol Online J 2011;9:9-36.
19. Kaya A, Goker B, Cura ES, et al. Turkish lupus PRO: cross-cultural validation study for lupus. Clin Rheumatol 2014;33:1079-84.
20. Al-Mayouf SM. Systemic lupus erythematosus in Saudi children: long-term outcomes. Int J Rheum Dis 2013;16:56-60.
21. Webb R, Kelly JA, Somers EC, et al. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Ann Rheum Dis 2011;70:151-6.
22. Criswell LA, Pfeiffer KA, Lum RF, et al. Analysis of Families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) Collection: the PTPN22 620W Allele Associates with Multiple Autoimmune Phenotypes. Am J Hum Genet 2005;76:561-71.
23. Ravelli A, Duarte-Salazar C, Buratti S, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: Amulticenter cohort study. Atrhritis Rheum 2003; 49:501-7.
24. Lilleby V, Flatø B, Førre O. Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus. Clin Exp Rheumatol 2005;23:261-9.